Yang-Gon Jin
Chief Executive Officer at HLB LIFE SCIENCE CO., LTD.
Net worth: 783 M $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Hyun-Su Lee | M | 53 |
Hyundai Yachts Co., Ltd.
 Hyundai Yachts Co., Ltd. Recreational ProductsConsumer Durables Hyundai Yachts Co., Ltd. is a South Korean company that manufactures and provides services for yachts. The private company is based in Seoul, South Korea.
Bada Heavy Industries
 Bada Heavy Industries Trucks/Construction/Farm MachineryProducer Manufacturing Founded in 1999, Bada Heavy Industries is a South Korean company that manufactures ship machinery and furniture.
Hyundai Lifeboats Singapore Pte Ltd.
HLB Networks Co., Ltd.
 HLB Networks Co., Ltd. Trucks/Construction/Farm MachineryProducer Manufacturing HLB Networks Co., Ltd. provides ship building and repairing services. Its services include hook replacement, inspection and maintenance, and service networks. The company was founded in 2009 and is headquartered in Ulsan, South Korea. | - |
| William G. Hearl | M | 66 |
Immunomic Therapeutics, Inc.
 Immunomic Therapeutics, Inc. BiotechnologyHealth Technology Immunomic Therapeutics, Inc. engages in the discovery and development of drugs. The firm specializes in DNA vaccines, lamp technology, allergy, oncology, animal health and infectious diseases. The company was founded by William G. Hearl, Bernard C. Rudnick and Thomas J. August and is headquartered in Rockville, MD. | 18 years |
| Soo Whan Choi | M | - |
Elevar Therapeutics, Inc.
 Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | 19 years |
| Ha-Young Kim | M | 53 |
HLB Cell Co., Ltd.
 HLB Cell Co., Ltd. BiotechnologyHealth Technology HLB Cell Co., Ltd. engages in the research and development of stem cell therapeutics. The company was founded on September 16, 2009 and is headquartered in Yongin, South Korea. | 11 years |
| Jung-Hwan Moon | M | 61 | - | |
| Wook Kim | M | 55 | 6 years | |
| Ki-Hong An | M | 57 | - | |
| Yeon-Sub Sim | M | 49 | 6 years | |
| Kyu-Jun Choi | M | 59 | 5 years | |
| Cheol-Soo Park | M | 51 | 5 years | |
| Jae-Hoon Kim | M | 59 | 3 years | |
| Jeong-Sang Lee | M | 49 | - | |
| Chang-Yoon Lim | M | 58 | - | |
| Do-Hyeong Kim | M | 44 | - | |
| Myeong-Gi Kim | M | 57 | - | |
| Han-Seung Koo | M | 59 | - | |
| Soo-Ja Choi | M | 59 | - | |
| Jae-Chul Sim | M | 68 | - | |
| Dong-Seok Jin | M | 43 | - | |
| Hyuk Joo Jee | M | - |
Immunomic Therapeutics, Inc.
Immunomic Therapeutics, Inc. BiotechnologyHealth Technology Immunomic Therapeutics, Inc. engages in the discovery and development of drugs. The firm specializes in DNA vaccines, lamp technology, allergy, oncology, animal health and infectious diseases. The company was founded by William G. Hearl, Bernard C. Rudnick and Thomas J. August and is headquartered in Rockville, MD. | 4 years |
| Geun-Shik Lee | M | 51 | - | |
| Sae-Ho Chong | M | - |
Elevar Therapeutics, Inc.
Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | 2 years |
| Tae-Geun Han | M | 50 | - | |
| Sang-Woo Nam | M | 66 | - | |
| Teri Jones Heiland | M | - |
Immunomic Therapeutics, Inc.
Immunomic Therapeutics, Inc. BiotechnologyHealth Technology Immunomic Therapeutics, Inc. engages in the discovery and development of drugs. The firm specializes in DNA vaccines, lamp technology, allergy, oncology, animal health and infectious diseases. The company was founded by William G. Hearl, Bernard C. Rudnick and Thomas J. August and is headquartered in Rockville, MD. | - |
| Jin-Gook Park | M | 76 | 7 years | |
| Sang-Hyun Sung | M | 59 | - | |
| Eul-gyoo Lee | M | 59 | 6 years | |
| Yong-Woong Kim | M | 65 | 12 years | |
| Doo-Hoon Lee | M | 55 |
HLB Cell Co., Ltd.
HLB Cell Co., Ltd. BiotechnologyHealth Technology HLB Cell Co., Ltd. engages in the research and development of stem cell therapeutics. The company was founded on September 16, 2009 and is headquartered in Yongin, South Korea. | 4 years |
| Sung-Je Kim | M | 58 | - | |
| Ki-Hwan Kim | M | 54 | - | |
| Gun Kim Dong | M | - |
Elevar Therapeutics, Inc.
Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | 4 years |
| Mi-Won No | F | 49 | - | |
| Carol Banquer | F | - |
Immunomic Therapeutics, Inc.
Immunomic Therapeutics, Inc. BiotechnologyHealth Technology Immunomic Therapeutics, Inc. engages in the discovery and development of drugs. The firm specializes in DNA vaccines, lamp technology, allergy, oncology, animal health and infectious diseases. The company was founded by William G. Hearl, Bernard C. Rudnick and Thomas J. August and is headquartered in Rockville, MD. | - |
| Yeok-Dong Kim | M | 64 | 3 years | |
| Keun Jang In | M | - |
Elevar Therapeutics, Inc.
Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | - |
| Seong-Hoon Jang | M | - |
Elevar Therapeutics, Inc.
Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | - |
| Young-Hyun Kim | M | 66 | - | |
| Do-Guk Son | M | 49 | - | |
| C. Eric Winzer | M | 67 |
Immunomic Therapeutics, Inc.
Immunomic Therapeutics, Inc. BiotechnologyHealth Technology Immunomic Therapeutics, Inc. engages in the discovery and development of drugs. The firm specializes in DNA vaccines, lamp technology, allergy, oncology, animal health and infectious diseases. The company was founded by William G. Hearl, Bernard C. Rudnick and Thomas J. August and is headquartered in Rockville, MD. | 9 years |
| Hoon Kim | M | 49 | 6 years | |
| In-Geun Jang | M | 48 | - | |
| Sang-Yong Park | M | 56 |
Immunomic Therapeutics, Inc.
Immunomic Therapeutics, Inc. BiotechnologyHealth Technology Immunomic Therapeutics, Inc. engages in the discovery and development of drugs. The firm specializes in DNA vaccines, lamp technology, allergy, oncology, animal health and infectious diseases. The company was founded by William G. Hearl, Bernard C. Rudnick and Thomas J. August and is headquartered in Rockville, MD. | 3 years |
| James Wishart | M | - |
Immunomic Therapeutics, Inc.
Immunomic Therapeutics, Inc. BiotechnologyHealth Technology Immunomic Therapeutics, Inc. engages in the discovery and development of drugs. The firm specializes in DNA vaccines, lamp technology, allergy, oncology, animal health and infectious diseases. The company was founded by William G. Hearl, Bernard C. Rudnick and Thomas J. August and is headquartered in Rockville, MD. | - |
| Ronald Thiboutot | M | - |
Immunomic Therapeutics, Inc.
Immunomic Therapeutics, Inc. BiotechnologyHealth Technology Immunomic Therapeutics, Inc. engages in the discovery and development of drugs. The firm specializes in DNA vaccines, lamp technology, allergy, oncology, animal health and infectious diseases. The company was founded by William G. Hearl, Bernard C. Rudnick and Thomas J. August and is headquartered in Rockville, MD. | - |
| Yoon-Gi Baek | M | 61 | - | |
| Yang-geun Moon | M | 55 |
HLB Cell Co., Ltd.
HLB Cell Co., Ltd. BiotechnologyHealth Technology HLB Cell Co., Ltd. engages in the research and development of stem cell therapeutics. The company was founded on September 16, 2009 and is headquartered in Yongin, South Korea. | - |
| Byung-Ro Lee | M | 68 | 6 years | |
| Dong-Gun Kim | M | 62 |
Immunomic Therapeutics, Inc.
Immunomic Therapeutics, Inc. BiotechnologyHealth Technology Immunomic Therapeutics, Inc. engages in the discovery and development of drugs. The firm specializes in DNA vaccines, lamp technology, allergy, oncology, animal health and infectious diseases. The company was founded by William G. Hearl, Bernard C. Rudnick and Thomas J. August and is headquartered in Rockville, MD. | - |
| Jong-Won Kim | M | 61 | - | |
| Young-Min Park | M | 63 | 5 years | |
| TImothy A. Coleman | M | - |
Immunomic Therapeutics, Inc.
Immunomic Therapeutics, Inc. BiotechnologyHealth Technology Immunomic Therapeutics, Inc. engages in the discovery and development of drugs. The firm specializes in DNA vaccines, lamp technology, allergy, oncology, animal health and infectious diseases. The company was founded by William G. Hearl, Bernard C. Rudnick and Thomas J. August and is headquartered in Rockville, MD. | - |
| Nahn Ho | M | 58 | 5 years | |
| Robert Verner Ahlgren | M | 71 |
Immunomic Therapeutics, Inc.
Immunomic Therapeutics, Inc. BiotechnologyHealth Technology Immunomic Therapeutics, Inc. engages in the discovery and development of drugs. The firm specializes in DNA vaccines, lamp technology, allergy, oncology, animal health and infectious diseases. The company was founded by William G. Hearl, Bernard C. Rudnick and Thomas J. August and is headquartered in Rockville, MD. | 3 years |
| Hyeok-Joo Ji | M | 57 | 6 years | |
| Hyun-gyu Go | M | 42 | - | |
| Bok-Hwan Jeon | M | 60 | - | |
| Soon-Ki Do | M | 55 | - | |
| Matthew Chang | M | 50 | - | |
| Chang-Hyun Baek | M | 57 | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Alex Kim | M | 56 |
Immunomic Therapeutics, Inc.
Immunomic Therapeutics, Inc. BiotechnologyHealth Technology Immunomic Therapeutics, Inc. engages in the discovery and development of drugs. The firm specializes in DNA vaccines, lamp technology, allergy, oncology, animal health and infectious diseases. The company was founded by William G. Hearl, Bernard C. Rudnick and Thomas J. August and is headquartered in Rockville, MD.
Elevar Therapeutics, Inc.
Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | 14 years |
| Kate McKinley | F | - |
Elevar Therapeutics, Inc.
Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | 3 years |
| Arlo McGinn | M | - |
Elevar Therapeutics, Inc.
Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT.
Immunomic Therapeutics, Inc.
Immunomic Therapeutics, Inc. BiotechnologyHealth Technology Immunomic Therapeutics, Inc. engages in the discovery and development of drugs. The firm specializes in DNA vaccines, lamp technology, allergy, oncology, animal health and infectious diseases. The company was founded by William G. Hearl, Bernard C. Rudnick and Thomas J. August and is headquartered in Rockville, MD. | - |
| Woo-Seung Maeng | M | 54 | 5 years | |
| Yoon-Ki Baek | M | 61 | 2 years | |
| Hae-Ja Jeong | M | 63 | - | |
| Mark Gelder | M | 67 |
Elevar Therapeutics, Inc.
Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | 1 years |
| Louise Peltier | F | - |
Immunomic Therapeutics, Inc.
Immunomic Therapeutics, Inc. BiotechnologyHealth Technology Immunomic Therapeutics, Inc. engages in the discovery and development of drugs. The firm specializes in DNA vaccines, lamp technology, allergy, oncology, animal health and infectious diseases. The company was founded by William G. Hearl, Bernard C. Rudnick and Thomas J. August and is headquartered in Rockville, MD. | 7 years |
| Bokhwan Chun | M | - |
Immunomic Therapeutics, Inc.
Immunomic Therapeutics, Inc. BiotechnologyHealth Technology Immunomic Therapeutics, Inc. engages in the discovery and development of drugs. The firm specializes in DNA vaccines, lamp technology, allergy, oncology, animal health and infectious diseases. The company was founded by William G. Hearl, Bernard C. Rudnick and Thomas J. August and is headquartered in Rockville, MD. | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| South Korea | 50 | 71.43% |
| United States | 22 | 31.43% |
| Singapore | 1 | 1.43% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Yang-Gon Jin
- Personal Network
